Vita Life SciencesASX:VLS -2.00%85 Days Inventory is 150.24 as of Dec. 2025, which is 5% below its 10-year median of 158.26. GuruFocus rates ASX:VLS with a GF Score™ of 85/100 and a GF Value™ of A$2.48 (Fairly Valued). The stock has 1 warning sign investors should review. Among 919 Drug Manufacturers companies, Vita Life Sciences ranks better than 53.75% on this metric.
The historical rank and industry rank for Vita Life Sciences's Days Inventory or its related term are showing as below:
ASX:VLS'
s Days Inventory Range Over the Past 10 Years
Min: 148.1 Med: 158.26 Max: 187.4
Current: 155.69
During the past 13 years, Vita Life Sciences's highest Days Inventory was 187.40. The lowest was 148.10. And the median was 158.26.
ASX:VLS's Days Inventory is ranked better than 53.75% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.83
vs ASX:VLS: 155.69
Vita Life Sciences's Days Inventory
declined
from Dec. 2024 (181.19) to Dec. 2025 (150.24).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vita Life Sciences's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.21.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vita Life Sciences's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.31.
Vita Life Sciences (ASX:VLS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vita Life Sciences's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vita Life Sciences's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vita Life Sciences Days Inventory Related Terms
Vita Life Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Vita Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vita Life Sciences Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vita Life Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vita Life Sciences (ASX:VLS) has a Days Inventory of 150.24 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vita Life Sciences and its competitors. This is near median its historical median of 158.26. Over the past decade, Vita Life Sciences' Days Inventory has ranged from 148.10 to 187.40. According to the industry distribution chart, Vita Life Sciences ranks #425 out of 919 companies in the Drug Manufacturers industry, placing it in the top 46.2%.
Is Vita Life Sciences' Days Inventory too high?
Vita Life Sciences' current Days Inventory of 150.24 is near median its 10-year median of 158.26. Over the past 10 years, this metric has ranged from a low of 148.10 to a high of 187.40. The Drug Manufacturers industry median Days Inventory is 162.83. Vita Life Sciences' value of 150.24 is 7.7% below this industry median. Based on the distribution chart, Vita Life Sciences ranks #425 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Vita Life Sciences has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vita Life Sciences' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vita Life Sciences ranks #425 out of 919 companies for Days Inventory. This puts Vita Life Sciences in the upper half of its industry. The industry median Days Inventory is 162.83. Vita Life Sciences' value of 150.24 is 7.7% below this benchmark. Historically, Vita Life Sciences' own Days Inventory has ranged from 148.10 to 187.40 over the past decade. While the company's 10-year median is 158.26 vs. the industry median of 162.83, Vita Life Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vita Life Sciences's current Days Inventory of 150.24 is 7.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vita Life Sciences and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vita Life Sciences's current Days Inventory is 150.24, which is near median its own 10-year median of 158.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vita Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Vita Life Sciences (ASX:VLS) is currently considered Fairly Valued. The stock's GF Value™ is A$2.48, compared to a current price of A$2.45 — trading 1.2% below its estimated fair value. The current Days Inventory is 150.24, which is near median its 10-year median of 158.26 and 7.7% below the Drug Manufacturers industry median of 162.83. Vita Life Sciences' overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vita Life Sciences (ASX:VLS), the current Days Inventory is 150.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vita Life Sciences (ASX:VLS) Overvalued in 2026?
Based on GuruFocus' analysis, Vita Life Sciences stock appears to be undervalued.
The current stock price of A$2.45 is trading 1.2% below its estimated GF Value™ of A$2.48.
GuruFocus considers Vita Life Sciences to be Fairly Valued.
Key valuation signals for ASX:VLS:
Days Inventory: 150.24 (near median its 10-year median of 158.26)
GF Value™: A$2.48 vs. price of A$2.45 (1.2% below fair value)
Industry Position: 7.7% below the Drug Manufacturers median (#425 of 919)
No single metric tells the full story. See the ASX:VLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.
85GF Score
Get the complete analysis for ASX:VLS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VLS has been successfully added to your 
